Johnson-Pratt Lisa 4

What Happened
Lisa Johnson-Pratt, a director of Assembly Biosciences (ASMB), received a grant of 8,000 stock options on June 4, 2026. The filing shows an acquisition at $0.00 (derivative grant), meaning no cash was paid at grant. This is a grant/award (code A) of options, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
• Instrument: 8,000 stock options granted (reported acquisition price $0.00; derivative transaction).
• Vesting: Options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 or (2) the Issuer’s 2027 annual meeting of stockholders (per footnote).
• Shares owned after transaction: not disclosed in the provided excerpt.
• No exercise or sale occurred; this is an award of options, not a cash exercise or disposition.
• No 10b5-1 plan, tax‑withholding, or late‑filing indication in the provided details.

Context
A grant of options gives the insider the right to buy shares in the future if vesting conditions are met; it does not change current share ownership until options are vested and exercised. Such grants are common as director compensation and are informative about compensation but are not the same as an outright purchase (which some investors view as a stronger bullish signal).